My two-year-course if Lupron and abiraterone will be done in March 2025. My MO is saying 2 years is sufficient but I see some people suggesting 3 years.
My situation. Dx in Feb 2023, PSA of 27. Gleason 4+3, BRACA2+, PSMA Pet showed three lymph nodes in pelvic area. 73 years old. Also diabetic and hypertension but both under control.
My treatments: brachytherapy, imrt, lupron, abiraterone. SE’s have been tolerable. Have even been able to rebuild muscles after hip replacement, although gained an inch or two at waist.
what are pro/cons of 2 yes vs 3yrs of ADT. Should I ask for 3 years?
Written by
BobC1234
To view profiles and participate in discussions please or .
Thanks for response. That explains it. Basically no one knows if two years is just as good as three years. Did the trial compare 3 yrs of ADT + 2 yrs of abi vs neither of these?
Also a more generic question to help my understanding: do trials generally tend to experiment first with a large dosage and then over time the required dosage can then be finetuned downward through clinical practice experience?
TA, thanks so much for your contributions to this site.
They tested 2 yrs abi + 3 yrs ADT vs 3 years of ADT. There is an ongoing clinical trial of 2 yrs of apalutamide+ADT vs 2 yrs of ADT. It just finished recruiting.
Dosage if the first thing they determine (Phase 1 trials).
well I’ve been on a ADT now for 8 years, no talk of going off . Had hip surgery on my left hip ( partial ) but wouldn’t do it without pinning the right hip due to cancer in my femur . Recovery was easy on the left but the right has been a nightmare as a piece of bone chipped off .surgery June 12 th. Still on a walker for the pin 🤬🤬🤬. Good luck warrior
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.